Spotlight on article published in
IBI Spotlights call attention to important health and productivity findings from peer-reviewed work. The research described in this particular Spotlight is authored or co-authored by an IBI researcher. IBI members are encouraged to obtain the original articles from the copyright holder.
What is the Issue?
Little is known about the full economic burden – in terms of workplace productivity, medical costs, employees’ lost wages, and national productive capacity – of cardiovascular conditions such as acute coronary syndrome (ACS).
What are the findings/solutions?
ACS imposes substantial economic burdens on both employers and employees (who lose income during periods of disability), but also on society at large in the form of lost productive capacity.
Page, R.L. II, Ghushchyan, V., Gifford, B., Read, R., Raut, M., Crivera, C., Naim, A., Damaraju, C.V., Nair, K.V. (2013). The Economic Burden of Acute Coronary Syndromes for Employees and Their Dependents. Journal of Occupational and Environmental Medicine. 55(7):761-767.
To determine the total burden of illness, including direct and indirect costs for employees and their dependents with acute coronary syndrome (ACS).
Medical and pharmacy claims along with short-term disability (STD) and long-term disability (LTD) claims from 2007 to 2010 were analyzed using two data sets: Integrated Benefits Institute’s Health and Productivity Benchmarking Database (STD and LTD claims) and IMS LifeLinkTM Health Plan Data (medical and pharmacy claims).
- Employees with ACS lost 60.2 ± 0.29 STD and 397.9 ± 8.09 LTD days per disability incident.
- For employers, the estimated average per claim productivity loss from STD and LTD was $7943 ± $39.7 and $52,473 ± $1114, respectively.
- Total annual ACS health care costs per employee were $8170 ± 106, with $7545 ± 104 for annual medical costs.
- Hospitalizations accounted for 75% of total annual ACS health care costs.
ACS imposes a substantial economic burden on employees, employers, and society.